Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05241279

Publication Date:

May 1, 2024

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.
The global Peptide API CDMO Services market size is projected to grow from US$ 2291 million in 2024 to US$ 5489 million in 2030; it is expected to grow at a CAGR of 15.7% from 2024 to 2030.
The 鈥淧eptide API CDMO Services Industry Forecast鈥� looks at past sales and reviews total world Peptide API CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide API CDMO Services sales for 2023 through 2029. With Peptide API CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide API CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Peptide API CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide API CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peptide API CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide API CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide API CDMO Services.
Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide API CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
GMP Services
Non-GMP Services
Segmentation by Application:
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
GMP Services
Non-GMP Services
Segmentation by Application:
Commercial
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Chinese Peptide Company
ScinoPharm
ChengDu ShengNuo Biotec
CBL
Piramal Pharma
CPC Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide API CDMO Services Market Size 2019-2030
2.1.2 Peptide API CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Peptide API CDMO Services by Country/Region, 2019, 2023 & 2030
2.2 Peptide API CDMO Services Segment by Type
2.2.1 GMP Services
2.2.2 Non-GMP Services
2.3 Peptide API CDMO Services Market Size by Type
2.3.1 Peptide API CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
2.4 Peptide API CDMO Services Segment by Application
2.4.1 Commercial
2.4.2 Scientific Research
2.4.3 Other
2.5 Peptide API CDMO Services Market Size by Application
2.5.1 Peptide API CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
3 Peptide API CDMO Services Market Size by Player
3.1 Peptide API CDMO Services Market Size Market Share by Player
3.1.1 Global Peptide API CDMO Services Revenue by Player (2019-2024)
3.1.2 Global Peptide API CDMO Services Revenue Market Share by Player (2019-2024)
3.2 Global Peptide API CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide API CDMO Services by Region
4.1 Peptide API CDMO Services Market Size by Region (2019-2024)
4.2 Global Peptide API CDMO Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Peptide API CDMO Services Market Size Growth (2019-2024)
4.4 APAC Peptide API CDMO Services Market Size Growth (2019-2024)
4.5 Europe Peptide API CDMO Services Market Size Growth (2019-2024)
4.6 Middle East & Africa Peptide API CDMO Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Peptide API CDMO Services Market Size by Country (2019-2024)
5.2 Americas Peptide API CDMO Services Market Size by Type (2019-2024)
5.3 Americas Peptide API CDMO Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide API CDMO Services Market Size by Region (2019-2024)
6.2 APAC Peptide API CDMO Services Market Size by Type (2019-2024)
6.3 APAC Peptide API CDMO Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide API CDMO Services Market Size by Country (2019-2024)
7.2 Europe Peptide API CDMO Services Market Size by Type (2019-2024)
7.3 Europe Peptide API CDMO Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide API CDMO Services by Region (2019-2024)
8.2 Middle East & Africa Peptide API CDMO Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Peptide API CDMO Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peptide API CDMO Services Market Forecast
10.1 Global Peptide API CDMO Services Forecast by Region (2025-2030)
10.1.1 Global Peptide API CDMO Services Forecast by Region (2025-2030)
10.1.2 Americas Peptide API CDMO Services Forecast
10.1.3 APAC Peptide API CDMO Services Forecast
10.1.4 Europe Peptide API CDMO Services Forecast
10.1.5 Middle East & Africa Peptide API CDMO Services Forecast
10.2 Americas Peptide API CDMO Services Forecast by Country (2025-2030)
10.2.1 United States Market Peptide API CDMO Services Forecast
10.2.2 Canada Market Peptide API CDMO Services Forecast
10.2.3 Mexico Market Peptide API CDMO Services Forecast
10.2.4 Brazil Market Peptide API CDMO Services Forecast
10.3 APAC Peptide API CDMO Services Forecast by Region (2025-2030)
10.3.1 China Peptide API CDMO Services Market Forecast
10.3.2 Japan Market Peptide API CDMO Services Forecast
10.3.3 Korea Market Peptide API CDMO Services Forecast
10.3.4 Southeast Asia Market Peptide API CDMO Services Forecast
10.3.5 India Market Peptide API CDMO Services Forecast
10.3.6 Australia Market Peptide API CDMO Services Forecast
10.4 Europe Peptide API CDMO Services Forecast by Country (2025-2030)
10.4.1 Germany Market Peptide API CDMO Services Forecast
10.4.2 France Market Peptide API CDMO Services Forecast
10.4.3 UK Market Peptide API CDMO Services Forecast
10.4.4 Italy Market Peptide API CDMO Services Forecast
10.4.5 Russia Market Peptide API CDMO Services Forecast
10.5 Middle East & Africa Peptide API CDMO Services Forecast by Region (2025-2030)
10.5.1 Egypt Market Peptide API CDMO Services Forecast
10.5.2 South Africa Market Peptide API CDMO Services Forecast
10.5.3 Israel Market Peptide API CDMO Services Forecast
10.5.4 Turkey Market Peptide API CDMO Services Forecast
10.6 Global Peptide API CDMO Services Forecast by Type (2025-2030)
10.7 Global Peptide API CDMO Services Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Peptide API CDMO Services Forecast
11 Key Players Analysis
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Peptide API CDMO Services Product Offered
11.1.3 Bachem Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide API CDMO Services Product Offered
11.2.3 PolyPeptide Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Peptide API CDMO Services Product Offered
11.3.3 CordenPharma Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Peptide API CDMO Services Product Offered
11.4.3 AmbioPharm Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Peptide API CDMO Services Product Offered
11.5.3 USV Peptides Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermo Fisher
11.6.1 Thermo Fisher Company Information
11.6.2 Thermo Fisher Peptide API CDMO Services Product Offered
11.6.3 Thermo Fisher Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermo Fisher Main Business Overview
11.6.5 Thermo Fisher Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Peptide API CDMO Services Product Offered
11.7.3 Bio Basic Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Peptide API CDMO Services Product Offered
11.8.3 JPT Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Peptide API CDMO Services Product Offered
11.9.3 Genscript Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Chinese Peptide Company
11.10.1 Chinese Peptide Company Company Information
11.10.2 Chinese Peptide Company Peptide API CDMO Services Product Offered
11.10.3 Chinese Peptide Company Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Chinese Peptide Company Main Business Overview
11.10.5 Chinese Peptide Company Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Peptide API CDMO Services Product Offered
11.11.3 ScinoPharm Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 ChengDu ShengNuo Biotec
11.12.1 ChengDu ShengNuo Biotec Company Information
11.12.2 ChengDu ShengNuo Biotec Peptide API CDMO Services Product Offered
11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 ChengDu ShengNuo Biotec Main Business Overview
11.12.5 ChengDu ShengNuo Biotec Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Peptide API CDMO Services Product Offered
11.13.3 CBL Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Peptide API CDMO Services Product Offered
11.14.3 Piramal Pharma Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Peptide API CDMO Services Product Offered
11.15.3 CPC Scientific Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂